Video game could help kids with diabetes take control
NCT ID NCT05923632
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing whether a specially designed digital game can help children aged 8-13 with type 1 diabetes improve their blood sugar control, confidence in managing their diabetes, and overall quality of life. The game is based on a health education model and will be played over 9 weeks. Researchers will measure changes in quality of life and self-efficacy using standard questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- digital game and health education
- What this could lead to
- If it works, this could offer a fun, engaging way to help children with type 1 diabetes better manage their condition and feel more confident.
- What could go wrong
- This is a small, early-stage study with only 58 participants. The game may not lead to meaningful improvements in blood sugar control or quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 58 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2024
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
8 to 13 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being in the 8-13 age range, * Being diagnosed with T1DM at least 6 months ago, * Ability to read and write Turkish, * Ability to communicate verbally, * To have Internet access, * Computer, tablet, etc. to have and use technological tools, * To volunteer to participate in the study Exclusion Criteria: • Having another chronic disease other than T1DM
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Children, only are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Bolu Abant İzzet Baysal Üniversitesi
RECRUITINGBolu, Turkey (Türkiye)
-
Zonguldak Bülent Ecevit Üniversitesi
RECRUITINGZonguldak, 67600, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Can a math model tune insulin pumps better than standard care?
- Can a group program stop eating disorders in type 1 diabetes?
- Inner ear clues to childhood balance problems put to the test
- Scientists map the inner Ear's balance signals in healthy kids
- Hearing loss in children may hide a balance problem, and doctors are testing for it